Conserved influenza virus epitopes

Conserved influenza virus epitopes are invariant regions of viral proteins that remain stable across various strains and subtypes, serving as the foundation for universal influenza vaccine development and broadly neutralizing antibody therapies (Krammer & Palese, Nature Reviews Drug Discovery, 2013). These epitopes are primarily located in the stalk region of hemagglutinin (HA), the ectodomain of matrix protein 2 (M2e), and internal proteins such as nucleoprotein (NP) and matrix protein 1 (M1) (Ekiert et al., Science, 2009). Unlike the immunodominant but highly variable HA head, these conserved regions are less susceptible to antigenic drift, allowing for the induction of cross-reactive immune responses (To et al., Expert Review of Vaccines, 2012). Therapeutic agents targeting these epitopes, such as broadly neutralizing antibodies (bnAbs), function by blocking viral entry, preventing membrane fusion, or facilitating the destruction of infected cells via antibody-dependent cellular cytotoxicity (ADCC) (Corti et al., Science, 2011). Additionally, T-cell-based vaccines targeting conserved internal epitopes aim to provide heterosubtypic protection by promoting the rapid clearance of virus-infected cells (Sridhar, Expert Review of Vaccines, 2014).

Other names

Universal influenza vaccine targetsBroadly reactive influenza epitopesConserved viral antigensCross-reactive influenza epitopesHA stalk epitopesM2e epitopes

Neutralization of viral entry, inhibition of membrane fusion, antibody-dependent cellular cytotoxicity (ADCC), and T-cell mediated clearance of infected cells.